Open Label Extension to Assess the Safety of Long-Term Treatment With Ampion for Severe Osteoarthritis (OA) of the Knee

NCT03349645 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
94
Enrollment
INDUSTRY
Sponsor class

Stopped Study terminated by Sponsor due to absence of significant safety findings.

Conditions

Interventions

Sponsor

Ampio Pharmaceuticals. Inc.